INHIBITORY EFFECTS OF QUASSINOIDS ON EPSTEIN-BARR-VIRUS ACTIVATION

被引:27
|
作者
OKANO, M
FUKAMIYA, N
TAGAHARA, K
TOKUDA, H
IWASHIMA, A
NISHINO, H
LEE, KH
机构
[1] KOBE PHARMACEUT UNIV,FAC PHARMACEUT SCI,KOBE 665,JAPAN
[2] KYOTO PREFECTURAL UNIV MED,DEPT BIOCHEM,KYOTO 602,JAPAN
[3] NATL INST CANC RES,DIV CANC PREVENT,TOKYO 103,JAPAN
[4] UNIV N CAROLINA,SCH MED,DIV MED CHEM & NAT PROD,NAT PROD LAB,CHAPEL HILL,NC 27599
关键词
ANTITUMOR PROMOTING EFFECT; EPSTEIN-BARR VIRUS ACTIVATION TEST; QUASSINOIDS; STRUCTURE-ACTIVITY RELATIONSHIPS;
D O I
10.1016/0304-3835(95)03839-O
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Short-term in vitro assays for tumor promoters and anti-tumor promoters (Epstein-Barr virus activation test) were carried out for 45 quassinoids. As a result, some quassinoids showed potent activity, more than 50% inhibition at a molar ratio of 1:1 (TPA/quassinoids). These results led to the following structure-activity relationships: (1) a methyleneoxy bridge and side chain enhance the activity and (2) a sugar moiety reduces the activity.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 50 条
  • [31] EPSTEIN-BARR-VIRUS IN LYMPHOMAS - A REVIEW
    JOSKE, D
    KNECHT, H
    BLOOD REVIEWS, 1993, 7 (04) : 215 - 222
  • [32] EPSTEIN-BARR-VIRUS TRANSFORMING PROTEIN
    HENDERSON, SA
    HUEN, D
    ROWE, M
    SEMINARS IN VIROLOGY, 1994, 5 (05): : 391 - 399
  • [33] Inhibitory effects of lantadenes and related triterpenoids on Epstein-Barr virus activation
    Inada, A
    Nakanishi, T
    Tokuda, H
    Nishina, H
    Iwashima, A
    Sharma, OP
    PLANTA MEDICA, 1995, 61 (06) : 558 - 559
  • [34] EPSTEIN-BARR-VIRUS - NEW INSIGHTS
    KIEFF, E
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05): : 1323 - 1324
  • [35] EPSTEIN-BARR-VIRUS IN CARCINOMA OF THE CERVIX
    WONG, KY
    COLLINS, RJ
    SRIVASTAVA, G
    PITTALUGA, S
    CHEUNG, ANY
    WONG, LC
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1993, 12 (03) : 224 - 227
  • [36] PROGRESS ON A VACCINE FOR EPSTEIN-BARR-VIRUS
    MARX, JL
    SCIENCE, 1986, 231 (4741) : 919 - 920
  • [37] NANOCRYSTALLINE EPSTEIN-BARR-VIRUS DECOYS
    KOSSOVSKY, N
    GELMAN, A
    SPONSLER, E
    MILLETT, D
    JOURNAL OF APPLIED BIOMATERIALS, 1991, 2 (04) : 251 - 259
  • [38] EPSTEIN-BARR-VIRUS SEROEPIDEMIOLOGY IN CHINA
    ZENG, Y
    PI, GH
    DENG, H
    ZHANG, JM
    WANG, PC
    WOLF, H
    DETHE, G
    AIDS RESEARCH, 1986, 2 : S7 - S15
  • [39] INHIBITORY EFFECTS OF CUCURBITANE TRITERPENOIDS ON EPSTEIN-BARR-VIRUS ACTIVATION AND 2-STAGE CARCINOGENESIS OF SKIN TUMOR .2.
    KONOSHIMA, T
    TAKASAKI, M
    KOZUKA, M
    NAGAO, T
    OKABE, H
    IRINO, N
    NAKASUMI, T
    TOKUDA, H
    NISHINO, H
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1995, 18 (02) : 284 - 287
  • [40] NASOPHARYNGEAL CARCINOMA AND EPSTEIN-BARR-VIRUS
    MONGIN, C
    GAILLARD, J
    HAGUENAUER, JP
    PIGNAT, C
    JOURNAL FRANCAIS D OTO-RHINO-LARYNGOLOGIE, 1986, 35 (04): : 189 - 194